adenine and fluorodeoxyglucose f18

adenine has been researched along with fluorodeoxyglucose f18 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Iozzo, P; Kalliokoski, KK; Lindroos, MM; Majamaa, K; Mari, A; Nuutila, P; Taittonen, MT; Tura, A1
Akhurst, TJ; Antonescu, CR; D'Adamo, DR; Dickson, MA; Keohan, ML; Maki, RG; Okuno, SH; Schwartz, GK1
Banerji, U; Castro, J; Lamanna, N; Mita, M; O'Brien, S; Saif, MW; Stogard, C; Takimoto, C; Von Hoff, D1
Francis, JH; Grommes, C; Hatzoglou, V; Krebs, S; Mauguen, A; Mellinghoff, IK; Schaff, LR; Schöder, H; Yildirim, O1
Dai, D; Hazle, JD; Jaffray, D; Jimenez, JE; Li, T; Lin, Y; Lu, Y; Macapinlac, HA; Pan, T; Wang, L; Wang, Z; Wu, J; Xu, G; Zhao, R1

Trials

2 trial(s) available for adenine and fluorodeoxyglucose f18

ArticleYear
Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:1

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; HSP90 Heat-Shock Proteins; Humans; Male; Middle Aged; Positron-Emission Tomography; Pyridines; Treatment Outcome

2013
A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jan-15, Volume: 20, Issue:2

    Topics: Adenine; Administration, Oral; Antineoplastic Agents; Biopsy; Drug Administration Schedule; Fluorodeoxyglucose F18; HSP90 Heat-Shock Proteins; Humans; Insulin-Like Growth Factor Binding Protein 2; Intracellular Space; Leukocytes, Mononuclear; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Pyridines; Receptor, ErbB-2

2014

Other Studies

3 other study(ies) available for adenine and fluorodeoxyglucose f18

ArticleYear
m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction.
    Diabetes, 2009, Volume: 58, Issue:3

    Topics: Adenine; Adult; Diabetes Mellitus; DNA, Mitochondrial; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Guanine; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Middle Aged; Muscle, Skeletal; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Reference Values

2009
Prognostic value of [
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:12

    Topics: Adenine; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoma, Non-Hodgkin; Piperidines; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Retrospective Studies; Tumor Burden

2021
Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma.
    Clinical nuclear medicine, 2022, Mar-01, Volume: 47, Issue:3

    Topics: Adenine; Fluorodeoxyglucose F18; Humans; Lymphoma; Piperidines; Positron Emission Tomography Computed Tomography; Retrospective Studies

2022